2013

Session 1

• Affordable Care Act and the Healthcare Marketplace (2nd PDF Here)
  Gregory R. Dill
• Practicing at the Top of your Profession
  Phil Burgess, RPh, MBA
• Patient Protection & Affordable Care Act (PPACA)
  Jenelle Sobotka, B.S., Pharm.D., FAPhA

Session 2

• Important Considerations for the Introduction of Biosimilars in the U.S.
  Frank A. Scappaticci, MD, PhD
• Biosimilars and the PPACA: Clinical Considerations and Educational Needs
  Christopher J. Topoleski
• Biosimilars: The Impact on Academic Pharmacy
  George E. MacKinnon III, PhD, MS, RPh, FASHP
• Biosimilars: A Pharmacy Benefit Manager (PBM) Perspective
  R. Falkenrath

Session 3

• Providing Innovative Health Care Delivery Utilizing Pharmacists: Medication Therapy Management Services Update
  Marialice S. Bennett, RPh, FAPhA
• Caring for Indigent Patients: Opportunities in a Health Care Reform Environment”
  Yolanda Hardy, PharmD
• 340B Partnerships
  Sandra F. Durley, PharmD
• Caring for Indigent Patients: Opportunities for Pharmacists in a Health Care Reform Environment
  Christie Schumacher, PharmD, BCPS, BC-ADM, CDE

Session 4

• Clinical Community Pharmacists
  Beverly Schaefer, RPh
• Innovative Ways to Utilize Medication Therapy Management
  Jim Gartner RPh, MBA
• Patient Protection & Affordable Care Act: Collaborative Practice & Its Impact – Proactivity and Reactivity
  Edward Langston, RPh, MD